Which segment accounted for the largest North America Veterinary Antimicrobial Susceptibility Testing Market share?

In terms of application, the livestock segment accounted for the largest market share. This is due to the high prevalence of infectious diseases in farm animals and routine monitoring, as companies like Neogen Corporation provide advanced testing kits for cattle, swine, and poultry health management.

Which type accounted for the largest North America Veterinary Antimicrobial Susceptibility Testing Market share?

The disk diffusion test type accounted for the largest market share, due to its cost-effectiveness, user-friendliness, and established reliability. Firms like bioMérieux SA offer widely adopted disk diffusion AST products, making them the preferred choice for veterinary diagnostic laboratories.

Home Healthcare

North America Veterinary Antimicrobial Susceptibility Testing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Veterinary Antimicrobial Susceptibility Testing Market
Brand: Bussiness Insights

North America Veterinary Antimicrobial Susceptibility Testing Market: by Type (Disk Diffusion, Agar Dilution, Broth Dilution, Automated AST, Gradient Diffusion, Others), Application (Livestock, Companion Animals, Aquaculture, Research, Diagnostic Laboratories, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Retail Pharmacies, Veterinary Clinics, Others), Technology (Phenotypic, Genotypic, Automated Systems, Manual Testing, Rapid Testing, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20443 | Author: Lily

RD TOC Segmentation Research Methodology Request For Free Sample

North America Veterinary Antimicrobial Susceptibility Testing Market Outlook 2025–2035

The North America Veterinary Antimicrobial Susceptibility Testing (AST) market provides solutions to gauge the effectiveness of antimicrobials against pathogens in animals, supporting responsible use of antibiotics in veterinary medicine. This sector incorporates both manual and automated testing methods, spanning disk diffusion, broth dilution, rapid and molecular tests, serving livestock, companion animals, aquaculture, and diagnostic and research laboratories. Growing concerns around antimicrobial resistance, stringent regulatory initiatives, and the adoption of technological advancements are driving market growth in the region. Leading players such as Thermo Fisher Scientific, BioMérieux, and BD offer a wide range of AST solutions utilizing genotypic and phenotypic methods, ensuring accuracy, speed, and improved workflow. As the market evolves, the integration of automation, digital data tracking, and point-of-care diagnostics are reshaping veterinary AST practices across North America.

Latest Market Dynamics

Key Drivers

Automation in Susceptibility Testing: Automated AST platforms are streamlining laboratory workflows, reducing manual errors, and enabling high-throughput testing. BD’s Phoenix Automated Microbiology System reflects this trend by offering seamless integration into veterinary labs.
Integration of Genotypic Testing: The use of molecular diagnostics for detecting resistance genes is gaining momentum, giving veterinarians deeper insights. Danaher Corporation’s recent genotypic AST kits exemplify this shift towards precision diagnostics.

Expansion into Rapid and Point-of-Care Testing: There is significant market potential for rapid AST solutions enabling on-site decision-making. Neogen Corporation is capitalizing on this opportunity by unveiling rapid lateral flow tests tailored for field use.
Emergence of Digital Data Platforms: Collaborative digital platforms that track AMR trends and share AST data across networks are in demand. Creative Diagnostics is enhancing its AST portfolio with digital data management capabilities, facilitating better surveillance.

High Cost of Advanced AST Systems: The adoption of highly automated, genotypic AST systems often requires substantial investment. Smaller clinics and diagnostic labs face budgetary constraints, even as product offerings from companies like Bruker expand.
Limited Access to Skilled Personnel: Successfully operating advanced AST instruments still demands trained technicians. This shortage is especially acute in rural or underserved areas, impacting reliable adoption despite improved solutions from vendors like Mast Group Ltd.

Lack of Standardization: The absence of uniform protocols across veterinary AST testing introduces variability and impacts testing reliability. Even with regulatory guidance, harmonization remains a hurdle for suppliers such as Liofilchem.
Complex Regulatory Approval Processes: Lengthy requirements for regulatory approval delay market entrance of innovative AST solutions, restraining the pace of product launches by companies like HiMedia Laboratories.

In 2025, Disk Diffusion remains the dominant testing type in the North America veterinary AST market, constituting the largest portion of market share. Automation and gradient diffusion techniques are experiencing a steady rise in adoption thanks to their precision and efficiency. However, traditional methods such as agar and broth dilution continue to be widely used, particularly in diagnostic labs and research institutions owing to their cost-effectiveness and familiarity. The market reflects a balanced blend of traditional and advanced AST methodologies as adoption of digital and automated solutions accelerates.

Livestock applications are projected to account for the largest share of the North American veterinary AST market in 2025, driven by high testing requirements in the food animal sector. Companion animals are the second-largest segment, fueled by rising pet ownership and intensifying focus on pet health. Aquaculture and diagnostic laboratory usage are steadily growing segments as well, benefiting from increased awareness and expanding regulatory oversight. This segmentation underscores the high utility and necessity of susceptibility testing across various animal health markets.

The revenue of the North America veterinary AST market demonstrated a consistent upward trend from 2020 to 2035. In 2025, the market size is anticipated to reach 460 Million USD, reflecting robust growth propelled by expanding adoption of AST solutions across both clinical and field settings. Factors such as growing regulatory focus on antimicrobial stewardship, technological innovation in rapid and automated diagnostics, and increased incidence of zoonotic diseases are major contributors to this upward trajectory. The market is expected to continue its growth momentum through 2035.

Year-on-year (YOY) growth rates in the North America veterinary AST market are projected to be strong throughout the forecast period. The market recorded impressive rise in 2025 at 8.1%, attributed mainly to technological advancements and regulatory momentum. Although YOY growth is expected to gradually moderate as the market matures, the sustained demand for antimicrobial stewardship and faster diagnostic solutions will support healthy growth rates till 2035.

In 2025, the United States is predicted to claim the largest share of the North America veterinary AST market, thanks to advanced veterinary infrastructure, higher livestock population, and strict regulatory monitoring. Canada follows with steady market growth, while Mexico, although representing a smaller share, is witnessing rising investments and improved veterinary service capacity. The regional landscape is defined by high technological uptake in the US and growing awareness across Canada and Mexico.

Thermo Fisher Scientific and BioMérieux lead the North America veterinary AST market with their comprehensive and advanced product offerings. Becton Dickinson & Company and Neogen Corporation follow, expanding their portfolios through innovation in automated and rapid testing platforms. The top five players collectively hold the majority of market share, reinforcing market consolidation and strong competitive dynamics. Recognized brands continue to drive industry standards and technological progress.

Diagnostic laboratories represent the largest segment among buyers in North America's veterinary AST market, followed by veterinary clinics and large-scale livestock producers. These entities are integrating advanced susceptibility testing into routine diagnostics to ensure appropriate antimicrobial use. Increasing collaborations between laboratories and producers, as well as the growing presence of veterinary clinics in both urban and rural areas, are shaping the buyer landscape in 2025.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	460
Regions	US, Canada, Mexico
Segments	Type (Disk Diffusion, Agar Dilution, Broth Dilution, Automated AST, Gradient Diffusion, Others), Application (Livestock, Companion Animals, Aquaculture, Research, Diagnostic Laboratories, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Retail Pharmacies, Veterinary Clinics, Others), Technology (Phenotypic, Genotypic, Automated Systems, Manual Testing, Rapid Testing, Others), Organization Size (Small, Medium, Large)
Players	Thermo Fisher Scientific, BioMérieux, Becton Dickinson & Company, Neogen Corporation, Danaher Corporation, Liofilchem, Creative Diagnostics, HiMedia Laboratories, Bioguard Corporation, Mast Group Ltd., Vetoquinol S.A., iNtRON Biotechnology Inc., Creative Diagnostics, Bruker Corporation, Alpha Labs

June 2024: Thermo Fisher Scientific launched an upgraded Sensititre RAPID AST plate tailored to veterinary pathogen detection.
July 2024: BioMérieux announced FDA compliance for its VITEK 2 AST system in veterinary use.
August 2024: Neogen expanded its rapid on-farm AST testing portfolio with lateral flow cassettes for livestock applications.
September 2024: Creative Diagnostics introduced a cloud-based data platform to enhance sharing of antimicrobial resistance insights.
October 2024: BD deployed a new training program to address skilled labor shortages in veterinary AST across North America.

About the Author

Lily

Senior Market Research Analyst

Lily is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Lily brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Lily has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America Veterinary Antimicrobial Susceptibility Testing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Veterinary Antimicrobial Susceptibility Testing Market Outlook 2025–2035

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

Market Share by Type in North America Veterinary Antimicrobial Susceptibility Testing, 2025

Market Share by Application in North America Veterinary AST Market, 2025

North America Veterinary Antimicrobial Susceptibility Testing Market Revenue (2020–2035)

Year-on-Year Growth (%) of North America Veterinary AST Market (2020–2035)

Regional Share (%) in North America Veterinary AST Market, 2025

Market Players’ Share (%) in North America Veterinary AST Market, 2025

Market Buyers’ Share (%) in North America Veterinary AST Market, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports